Search research articles
Contact Us
Filters
Showing results (91-100 of 185) with videos related to
Page
of 19
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 23, 2025
Intratumoral or Subcutaneous MK-2118, a Noncyclic Dinucleotide STING Agonist, with or without Pembrolizumab, for Advanced or Metastatic Solid Tumors or Lymphomas
Jason J Luke, Randy F Sweis, J Randolph Hecht, et al.
International Journal of Radiation Oncology, Biology, Physics
|
June 26, 2022
Predictors of Pneumonitis in Combined Thoracic Stereotactic Body Radiation Therapy and Immunotherapy
Mark C Korpics, Rohan R Katipally, Julien Partouche, et al.
Journal for Immunotherapy of Cancer
|
October 16, 2014
Ipilimumab administration for advanced melanoma in patients with pre-existing Hepatitis B or C infection: a multicenter, retrospective case series
Sowmya Ravi, Kristen Spencer, Mary Ruisi, et al.
JAMA Network Open
|
February 17, 2026
Adjuvant Pembrolizumab for Stage IIB or IIC Melanoma: A Secondary Analysis of a Randomized Clinical Trial
Sancy A Leachman, Jason J Luke, Paolo A Ascierto, et al.
Cancer Immunology Research
|
April 5, 2017
Diagnostic Comparison of CT Scans and Colonoscopy for Immune-Related Colitis in Ipilimumab-Treated Advanced Melanoma Patients
Marlene Garcia-Neuer, Melina E Marmarelis, Sushrut R Jangi, et al.
Medrxiv : the Preprint Server for Health Sciences
|
November 24, 2025
Multiregional CT Features Improve Prediction of Immunotherapy Response in Advanced Melanoma
Grant Kokenberger, Jatin Singh, Drew Hurd, et al.
British Journal of Cancer
|
April 22, 2023
Phase I/II sequencing study of azacitidine, epacadostat, and pembrolizumab in advanced solid tumors
Jason J Luke, Marwan Fakih, Charles Schneider, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 28, 2019
Randomized Phase II Trial and Tumor Mutational Spectrum Analysis from Cabozantinib versus Chemotherapy in Metastatic Uveal Melanoma (Alliance A091201)
Jason J Luke, Daniel J Olson, Jacob B Allred, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 7, 2022
Phase I Study of Safety, Tolerability, and Efficacy of Tebentafusp Using a Step-Up Dosing Regimen and Expansion in Patients With Metastatic Uveal Melanoma
Richard D Carvajal, Paul Nathan, Joseph J Sacco, et al.
Journal for Immunotherapy of Cancer
|
March 15, 2022
Exploring the safety, effect on the tumor microenvironment, and efficacy of itacitinib in combination with epacadostat or parsaclisib in advanced solid tumors: a phase I study
Aung Naing, John D Powderly, John J Nemunaitis, et al.
Page
of 19
Search research articles
Search
Showing results (91-100 of 185) with videos related to
Sort By:
Page
of 19
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 23, 2025
Intratumoral or Subcutaneous MK-2118, a Noncyclic Dinucleotide STING Agonist, with or without Pembrolizumab, for Advanced or Metastatic Solid Tumors or Lymphomas
Jason J Luke, Randy F Sweis, J Randolph Hecht, et al.
International Journal of Radiation Oncology, Biology, Physics
|
June 26, 2022
Predictors of Pneumonitis in Combined Thoracic Stereotactic Body Radiation Therapy and Immunotherapy
Mark C Korpics, Rohan R Katipally, Julien Partouche, et al.
Journal for Immunotherapy of Cancer
|
October 16, 2014
Ipilimumab administration for advanced melanoma in patients with pre-existing Hepatitis B or C infection: a multicenter, retrospective case series
Sowmya Ravi, Kristen Spencer, Mary Ruisi, et al.
JAMA Network Open
|
February 17, 2026
Adjuvant Pembrolizumab for Stage IIB or IIC Melanoma: A Secondary Analysis of a Randomized Clinical Trial
Sancy A Leachman, Jason J Luke, Paolo A Ascierto, et al.
Cancer Immunology Research
|
April 5, 2017
Diagnostic Comparison of CT Scans and Colonoscopy for Immune-Related Colitis in Ipilimumab-Treated Advanced Melanoma Patients
Marlene Garcia-Neuer, Melina E Marmarelis, Sushrut R Jangi, et al.
Medrxiv : the Preprint Server for Health Sciences
|
November 24, 2025
Multiregional CT Features Improve Prediction of Immunotherapy Response in Advanced Melanoma
Grant Kokenberger, Jatin Singh, Drew Hurd, et al.
British Journal of Cancer
|
April 22, 2023
Phase I/II sequencing study of azacitidine, epacadostat, and pembrolizumab in advanced solid tumors
Jason J Luke, Marwan Fakih, Charles Schneider, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 28, 2019
Randomized Phase II Trial and Tumor Mutational Spectrum Analysis from Cabozantinib versus Chemotherapy in Metastatic Uveal Melanoma (Alliance A091201)
Jason J Luke, Daniel J Olson, Jacob B Allred, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 7, 2022
Phase I Study of Safety, Tolerability, and Efficacy of Tebentafusp Using a Step-Up Dosing Regimen and Expansion in Patients With Metastatic Uveal Melanoma
Richard D Carvajal, Paul Nathan, Joseph J Sacco, et al.
Journal for Immunotherapy of Cancer
|
March 15, 2022
Exploring the safety, effect on the tumor microenvironment, and efficacy of itacitinib in combination with epacadostat or parsaclisib in advanced solid tumors: a phase I study
Aung Naing, John D Powderly, John J Nemunaitis, et al.
Page
of 19